Navigation Links
Breast reconstruction advances fix distortions left by lumpectomy
Date:4/23/2008

ARLINGTON HEIGHTS, Ill. Lumpectomy or breast conservation surgery is the most common type of breast cancer surgery currently performed. A benefit of the surgery is that only part of the breast is removed, but a drawback can be the resulting physical appearance of the breast, which may be disfigured, dented or uneven. A report in Aprils Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS), examines advances plastic surgeons have made in breast reconstruction to repair the damage left when cancer is removed.

Although breast conversation therapies are a huge advance in the treatment of breast cancer, women are still concerned about how their breast will look after surgery, said Sumner Slavin, MD, ASPS Member and report co-author. Breast conservation surgery or lumpectomy can mean many things; a biopsy, partial mastectomy, wedge resection, or having a quarter of the breast taken. Women are often left with portions of their breasts removed and there are currently no implants that can address this unique cosmetic issue.

After lumpectomy or breast conservation surgery, plastic surgeons are now approaching the challenge of misshapen breasts by immediately remodeling the breast with remaining breast tissue or tissue taken from another area of the body. The result is a more natural looking breast that is more symmetrical with the unaffected breast.

Three additional advances the report examines are nipple-sparing mastectomy, deep inferior epigastric perforator (DIEP) flaps and acellular dermis graft slings. These are options for women who require a full mastectomy and young women who opt for preventative mastectomy due to a strong family history of breast cancer.

In nipple-sparing surgery, cancerous tissue and the duct system of the breast are removed, but a pocket of skin, the nipple and areola are saved. Plastic surgeons insert either an implant or the patients
'/>"/>

Contact: ASPS Public Relations
media@plasticsurgery.org
847-228-9900
American Society of Plastic Surgeons
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Breast Reconstruction Advances Fix Distortions Left by Lumpectomy
2. Vitamin D and breast cancer risk
3. Millions of Euros could be saved if breast cancer follow-ups were led by specialist nurses
4. Acupuncture relieves hot flushes in breast cancer patients taking tamoxifen
5. Breast-Feeding While on Seizure Meds Doesnt Harm Babies
6. Genome analysis reveals new protein associated with breast cancer progression
7. Weekly Doses of Taxol Prolonged Lives of Breast Cancer Patients
8. Breast cancer risk amplified by additional genes in combo with BRCA mutation
9. Research collaboration seeks blood test for aggressive breast cancer
10. MRI before surgery leads to better-adapted treatment for breast cancer
11. Obese women disadvantaged in both breast cancer treatment and diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)... This December, and on the eve of its 35t...HC) will launch an integrated Season of Giving mar...help goes a long way. The initiative, designed to ...s for the Charity and its three core programs: Ron...d the Ronald McDonald Care Mobile. , ...
(Date:12/4/2008)...Toy Safety Program Offers Manufacturers A Way to I... the NewConsumer Product Safety Improvement Act ,...wswire/ -- Recent toy recalls continue to generate...r children,s toys, reinforcing the importance of t...ion -- integrated services that include auditing, ...
(Date:12/4/2008)...on available in global compliance and ethics onlin...-USNewswire/ -- The Society of Corporate Complianc... Association (HCCA) announced today the associatio... to all compliance and ethics professionals beginn... the social network sites and participate in the o...
(Date:12/4/2008)...th Care Brought Closer to More Veterans , , ...erans will have easier access to world-class healt... plan to open 31 new outpatient clinics in 16 stat... James B. Peake today announced VA will establish ...ida, Georgia, Hawaii, Illinois, Iowa, Maryland, Mi...
Breaking Medicine News(10 mins):Health News: Ronald McDonald House Charities Brings People Together Like Never Before with First-Ever, Multi-Channel Social Networking Campaign : Charity Finds New Ways to Encourage Seasonal Giving in Tough Economic Times 2Health News: Ronald McDonald House Charities Brings People Together Like Never Before with First-Ever, Multi-Channel Social Networking Campaign : Charity Finds New Ways to Encourage Seasonal Giving in Tough Economic Times 3Health News:NSF International Offers Answers to Rising Toy Safety Concerns 2Health News:SCCE and HCCA Social Network Now Open to All Compliance and Ethics Professionals 2Health News:SCCE and HCCA Social Network Now Open to All Compliance and Ethics Professionals 3Health News:VA Opening 31 New Outpatient Clinics 2
...eye from a dead body kept at Bhilai Steel Plant (B... Saturday.// The incident that took place Friday ...m here. The deceased, 32-year-old C.H. Srinivas, w... last week after he met with a road accident. "So...
...me to the Brampton, Ont., Tim Horton's location ar...epatitis A.// According to health officials in Pe...n at 2 Intermodal Dr. has tested positive for hepa...cal officer of the health, Dr. Eileen De Villa, ha...
...at fibrin fibers could stretch to three times its ...ile some could even stretch to six times// their o...n blood clotting is developed in the blood from a ...injury occurs fibrin is deposited around the wound...
... denied admission to a medical college here becaus...7 percent disability, has urged President// A.P.J.... in the Scheduled Tribe category of the state join...ission to the VSS Medical College in Burla. The co...
Other Medicine News:
(Date:12/2/2008)...ratories, a leading clinical-diagnostics and biom...ogy and allergy assays, announced that it has laun...nts whose immune systems may be compromised due to... drugs, or because they are taking immuno-suppress...e company launched the two new assays, the T Cell...
(Date:12/2/2008)...Therapeutics, Inc., a,privately held biopharmaceu...hase 3 trials evaluating its lead investigational ...ints. HZT-501, a novel, proprietary fixed-dose,co...ine, demonstrated a,statistically significant red...lammatory drug (NSAID)-induced upper gastrointesti...
(Date:12/1/2008)...w research has found that the availability of a po...r in an emergency room can significantly increase ...ally life-saving treatment. Results of the study, ...em Hospital in Salem, Mass., will be presented tod...ty of North America (RSNA). , , "The hospit...
(Date:12/1/2008)... -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA ) r...ld,s leading medical journals, results of clinical...ntal compound tasimelteon (VEC-162). The publicat...agonist tasimelteon (VEC-162) for transient insomn...ed multicentre trials." Results are reported from ...
Breaking Medicine Technology:IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Law Offices of Howard G Smith Announces Investigation on Behalf of Current and Former Employees of Merck 26 Co Inc Who Invested in the Merck 26 16441 1Haemacure Reports on its annual general and special meeting of shareholders 16438 1Haemacure Reports on its annual general and special meeting of shareholders 16438 2Haemacure Reports on its annual general and special meeting of shareholders 16438 3Haemacure Reports on its annual general and special meeting of shareholders 16438 4Landmark Study Aims to Improve Osteoporosis Care Standards Worldwide 16435 1Landmark Study Aims to Improve Osteoporosis Care Standards Worldwide 16435 2Landmark Study Aims to Improve Osteoporosis Care Standards Worldwide 16435 3Vanishing polar ice talk to be Webcast live April 10 2838 1
..., Switzerland, April 3, 2007 (PRIME NEWSWIRE) -- N...logical and,pharmacokinetic profiles of Basilea,s ...role and isavuconazole. Studies reported,both for ...ephalosporin in late-stage development, and for is...vasive fungal infections,yielded further data on ...
... France, April 04, 2007 /PRNewswire/ -- Novagali P...ny specialized in,ophthalmology, announces today p...of Vekacia(R) in children suffering from Vernal,Ke...it was shown,that both symptoms and signs of disea...hermore, the tolerability to Vekacia(R),was excell...
Other Medicine Technology:Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 2Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 3Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 4Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 5Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 6Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 7Novagali Pharma Announces Positive Vekacia Clinical Results From,Pivotal Phase III Trial in Vernal Keratoconjunctivitis 2
Performa cemented stem.
Porous foundation 470 series.
The AcuMatch M-Series modular femoral stem is a unique, innovative three-piece modular stem designed to address even the most complicated of clinical indications.
The link classic plus hip stem for cemented primary hip replacement surgery
Medicine Products: